Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Aug 3, 2022, after the close
10-Q filed Aug 3, 2022, 34 days after period end · 0001564590-22-027784
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $43.66M | $38.51M | $20.99M | $22.14M |
| Net Income | -$52.05M | -$49.30M | -$33.54M | -$15.66M |
| EPS Diluted |
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR
| -$0.37 |
| -$0.35 |
| -$0.26 |
| -$1.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.